Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What CAGR Is Anticipated for the Tubeless Insulin Pump Market Through 2029?
The market size of tubeless insulin pumps has seen significant proliferation in the past few years. The market is projected to increase from $1.84 billion in 2024 to $2.20 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 19.5%. The historical growth period’s significant contributors include an increase in diabetes cases, a surge in demand for unobtrusive and convenient insulin delivery, enhanced understanding of diabetes management, improved compensation policies, patients’ inclination towards insulin administration without discomfort, and the development of home healthcare services.
The market for tubeless insulin pumps is predicted to experience a significant expansion over the upcoming years. The market is projected to reach $4.44 billion by 2029, with a compound annual growth rate (CAGR) of 19.1%. Factors contributing to this predicted growth within the forecast period include rising demand for discreet and easy-to-use insulin delivery systems, increased emphasis on tailored diabetes management methods, broadening of reimbursement policies for sophisticated insulin devices, and heightened awareness born from digital health campaigns. Key trends to note during this forecast period are the integration of AI-assisted glucose monitoring, improved connectivity with smartphone apps, reduction in size of patch devices, increased usage of closed-loop systems, and the embrace of wearable health technologies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27440&type=smp
What Market Forces Are Driving The Tubeless Insulin Pump Sector In 2025 And Beyond?
The rise in diabetes cases is anticipated to fuel the expansion of the tubeless insulin pump market. Diabetes, a long-term health problem that elevates blood sugar levels due to the body’s failure to produce or utilize insulin correctly, is primarily increasing due to growing obesity rates relating to poor diet and physical inactivity. Tubeless insulin pumps aid diabetes management by delivering consistent, controlled insulin doses, eliminating the need for multiple injections daily, thereby effectively regulating blood sugar levels. In June 2023, for example, the US-based public health research institute, the Institute for Health Metrics and Evaluation, revealed that over half a billion individuals worldwide were diagnosed with diabetes. This figure is projected to more than double, hitting 1.3 billion people by 2050. Thus, the escalating diabetes instances are accelerating the tubeless insulin pump market’s growth.
How Is The Global Tubeless Insulin Pump Market Categorized By Segments?
The tubeless insulin pump market covered in this report is segmented
1) By Product: Wearable Insulin Pump, Implantable Insulin Pump
2) By Technology: Continuous Glucose Monitoring (CGM) Integrated Pumps, Standard Tubeless Pumps
3) By End User: Hospitals, Pharmacies, E-Commerce, Other End Users
Subsegments:
1) By Wearable Insulin Pump: Patch Pumps, Remote-Controlled Pumps, Bluetooth-Enabled Pumps, Disposable Pumps, Reusable Pumps
2) By Implantable Insulin Pump: Programmable Implantable Pumps, Refillable Implantable Pumps, Microelectromechanical System (MEMS)-Based Pumps, Long-Acting Implantable Pumps, Biocompatible Coated Pumps
What Long-Term Trends Are Likely To Affect The Tubeless Insulin Pump Market?
Key players in the tubeless insulin pump industry are concentrating on the enhancement of their offerings with innovative solutions such as basal-only insulin pods. These serve as a convenient and affordable method for insulin delivery, specifically targeting individuals with type 2 diabetes who predominantly need background insulin support. A basal-only insulin pod is a wearable device that constantly supplies background insulin to regulate blood sugar, specifically designed for those living with type 2 diabetes. For instance, in April 2023, Insulet Corporation, a medical device firm based in the United States, introduced Omnipod GO. This insulin delivery mechanism is certified for usage by type 2 diabetes patients aged 18 and above who routinely require injections of long-acting insulin. The Omnipod GO is a self-contained, wearable insulin delivery system that provides a steady stream of rapid-acting insulin for a duration of 72 hours. It also incorporates a tubeless, water-resistant pod available in seven varied pre-set daily rates, with quantities ranging from 10 to 40 units each day, and operates autonomously without reliance on a mobile device for regulation.
Which Firms Are Considered Leaders In The Tubeless Insulin Pump Market Space?
Major companies operating in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, and Beta Bionics.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/tubeless-insulin-pump-global-market-report
What Role Do Regional Policies And Investments Play In Tubeless Insulin Pump Market Expansion?
North America was the largest region in the tubeless insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tubeless insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27440&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model